Impairment of Circulating CD4+CD25+GARP+ Regulatory T Cells in Patients with Acute Coronary Syndrome

Cellular Physiology and Biochemistry

关键词: Atherosclerosis;    Regulatory T cells;    GARP;    Immune system;    Acute coronary syndrome;   

DOI  :  10.1159/000358639

学科分类：分子生物学，细胞生物学和基因

来源: S Karger AG

【 摘 要 】

Background Atherosclerosis (AS) is an inflammatory and immune disease. Regulatory T cells (Tregs) suppress the activation of T cells and have been shown to play a protective role during the pathogenesis of AS. However, specific markers for Tregs are lacking. Recently, glycoprotein A repetitions predominant (GARP) was discovered as a specific marker of activated Tregs, and we therefore utilized GARP as a specific surface marker for Tregs in the current study. Methods To assess whether GARP⁺ Tregs are downregulated in patients with acute coronary syndrome (ACS), we examined CD4⁺CD25⁺GARP⁺ T cell frequencies as well as their associated cytokines and suppressive function. Additionally, we compared GARP expression to that of FOXP3, which may be more sensitive as a marker of activated Tregs in patients with ACS. Results Patients with ACS demonstrated a significant decrease in circulating CD4⁺CD25⁺GARP⁺ Tregs. Moreover, the suppressive function of Tregs and levels of related cytokines were also impaired in ACS patients compared to those with stable angina (SA) or normal coronary artery (NCA). Additionally, after TCR stimulation, peripheral blood mononuclear cells (PBMCs) from patients with ACS exhibited a decrease in CD4⁺CD25⁺GARP⁺ Tregs. Conclusions These fnding indicate that circulating CD4⁺CD25⁺GARP⁺ Tregs are impaired in patients withACS. Thus, targeting GARP may promote the protective function of Tregs in ACS.

【 授权许可】

CC BY-NC-ND